Ticker > IPO > New Listed IPO > Concord Biotech Ltd.

Concord Biotech Ltd. IPO

The company is a leading India-based biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology. With a significant global market share, the company supply to over 70 countries, including regulated markets. Its sustainable manufacturing capabilities and focus on therapeutic areas like immunology and oncology drive its success in the dynamic biopharma industry.

RHP
View
DRHP
View
Open Date

2023-08-04

Close Date

2023-08-08

IPO Details

Check out the issue details for Concord Biotech Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 741

Price Band

₹ 705 - 741

Issue Size

1551 Cr.

Issue Type

Book Built

Open

2023-08-04

Close

2023-08-08

Listingprice

₹ 900.05

ListingGain

21.46%

Listing Date

2023-08-18

CMP

₹ 1650.45

Current Return

122.73%

News

Concord Biotech informs about updates 6 Mar, 5:22PM Concord Biotech gets GMP for unit II of Gujarat facility23 Feb, 11:46AM Concord Biotech informs about investor presentation9 Feb, 1:20PM Concord Biotech - Quaterly Results8 Feb, 6:15PM Concord Biotech - Quaterly Results8 Feb, 6:15PM Concord Biotech informs about board meeting30 Jan, 4:12PM Concord Biotech informs about analyst meet14 Dec, 5:24PM Concord Biotech - Quaterly Results8 Nov, 3:19PM Concord Biotech - Quaterly Results8 Nov, 3:19PM Concord Biotech informs about updates11 Oct, 4:21PM Concord Biotech informs about conference call13 Sep, 5:17PM Concord Biotech - Quaterly Results6 Sep, 3:44PM Concord Biotech - Quaterly Results6 Sep, 3:44PM Concord Biotech - Quaterly Results6 Sep, 3:44PM Concord Biotech gets EIR from USFDA for Gujarat facility 18 Aug, 4:00PM Concord Biotech coming up with IPO to raise upto Rs 1551 crore2 Aug, 3:05PM Concord Biotech to come out with Rs 1,550 crore IPO on August 4 31 Jul, 12:47PM

Company Financials

You can get the following financial statements of Concord Biotech Ltd. as of now.

Company Name

Concord Biotech Ltd.

Exchange

NSE: CONCORDBIO BSE: 543960

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Subscription Details

The details about the Concord Biotech IPO is as:

  • The issue size of the Concord Biotech IPO is 1551 Cr.
  • The price band for Concord Biotech IPO is Rs 705 to Rs 741.
  • The shares of Concord Biotech IPO will list on 18th August 2023.
  • The latest tentative GMP of Concord Biotech IPO is Rs 150.
  • The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023.

 

Concord Biotech IPO Valuation

The approx valuation of Concord Biotech IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 741
Existing Shares (Qty) 10.46 Cr
Market Cap 7750.86 Cr
EPS (FY23) Rs 22.95
PE Ratio 32.28x
Industry PE 35.98x

 

Concord Biotech IPO Issue Size

Concord Biotech IPO issue size is 1551 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 1551 Cr

 

Concord Biotech IPO Market Lot

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,820
 Maximum 13 260 Rs 1,92,660

 

Concord Biotech IPO Offer

The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 67.67 Times
Non-Institutional Minimum 15% 16.99 Times
Retail Individual Minimum 35% 3.78 Times
Employee 10000 Shares 24.48 Times
Total   24.87 Times

 

Concord Biotech IPO Grey Market Premium

As on GMP (Tentative)
6 August 2023 Rs 150
7 August 2023 Rs 200
8  August 2023 Rs 160
9 August 2023 Rs 140
10 August 2023 Rs 160
13  August 2023 Rs 160
14  August 2023 Rs 150

Concord Biotech IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

Allotment Details

Find below the dates for Concord Biotech Ltd IPO: 

Schedule Date
Basis of Allotment 11 August 2023
Refunds 14 August 2023
Credit to Demat Account 17 August 2023
IPO Listing Date 18 August 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 436.01 512.33 616.94 712.93 853.17
Total Expenditure 255.29 307.79 289.01 439.01 504.59
Operating Profit 180.72 204.54 327.93 273.93 348.58
Other Income 17.44 31.37 13.81 23.42 35.31
Interest 0.93 1.17 1.05 6.13 9.8
Depreciation 19.31 21.25 27.52 50.05 54.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 177.92 213.49 313.17 241.16 320.05
Provision for Tax 59.53 44.53 77.83 62.59 81.93
Net Profit 118.39 168.96 235.29 178.57 238.13
Adjusted EPS (Rs.) 1.13 1.62 2.25 1.71 2.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 9.51 9.51 9.51 9.51 10.46
Total Reserves 672.99 760.57 990.16 1097.65 1281.52
Borrowings 0 35.53 56.25 31.25 6.24
Other N/C liabilities 22.97 19.66 151.37 212.23 219.45
Current liabilities 54.2 223.27 105.74 151.89 181.53
Total Liabilities 759.67 1048.54 1313.03 1502.53 1699.2
Assets
Net Block 229.7 239.6 546.22 572.98 592.98
Capital WIP 18.99 141.4 17.95 74.16 172.7
Intangible WIP 0 0 0 0 0
Investments 0 0.67 0.67 0.92 0.79
Loans & Advances 10.69 19.44 140.61 220.99 196.84
Other N/C Assets 0.31 0.67 0.45 0.82 8.19
Current Assets 499.97 646.76 607.15 632.67 727.7
Total Assets 759.67 1048.54 1313.03 1502.53 1699.2
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023
Other Income 6.65 8.13 8.19
Profit Before Tax 65.01 113.18 100.09
Tax 16.54 28.69 25.53
Profit After Tax 48.47 84.49 74.55
Adjusted EPS (Rs) 4.63 8.08 7.13

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 44.08 0
Dec 2023 44.08 0
Sep 2023 44.08 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 177.92 213.49 313.17 241.16 320.05
Adjustment 7.84 12.27 17.59 49.16 48.51
Changes in Assets & Liabilities 32.86 -21.85 -88.77 -22.06 -52.29
Tax Paid -55.72 -49.1 -75.18 -60.78 -70.28
Operating Cash Flow 162.9 154.81 166.81 207.47 246
Investing Cash Flow -116.32 -112.74 -195.2 -111.79 -157.95
Financing Cash Flow -44.52 -43.41 31.12 -100.16 -85.22
Net Cash Flow 2.07 -1.35 2.74 -4.48 2.83
X